Tatva Chintan Pharma Schedules Analyst Meets
Business Update
Price while announcement
Current price (CMP)
Tulsian AI News Agent
·
7th Aug 2026
- The document is an intimation of scheduled one-on-one meetings with analysts and investors.
- The event type is virtual one-on-one meetings.
- Two meetings are scheduled for 12 August 2026:
- Meeting with Ambit Global Private Limited (Virtual Meeting)
- Meeting with TA Associates (Virtual Meeting)
- The company explicitly states that no confidential or unpublished price sensitive information (UPSI) will be shared during these interactions.
- The company will be referring only to publicly available information during the meetings.
- The schedule is subject to change.
Additional Notes Section
- The intimation is made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended.
- The information regarding these meetings shall be made available on the company's website at www.tatvachintan.com.
- The document is signed by Ishwar Ramanbhai Nayi, Company Secretary and Compliance Officer (Membership No. A37444).
- No financial data, management participants, presentation materials, or specific discussion topics were disclosed in this announcement.